Curative Biotechnology INC

S-1

New Public Companies (S-1)

OID
CUBT
Curative Biotechnology INC
S-1/A: Curative Biotechnology Files S-1/A for $10 Million Public Offering Amidst Going Concern Warning and Extensive Debt Restructuring
Curative Biotechnology, Inc. is seeking to raise $10 million through a firm commitment public offering of common stock, coupled with a 1-for-400 reverse stock split and a planned NYSE American listing, as the development-stage biotech company grapples with significant accumulated losses and a going concern qualification from its auditors.
Delay expected
Capital raise
Worse than expected
OID
CUBT
Curative Biotechnology INC
S-1: Curative Biotechnology Amends Executive Agreements, Eyes Potential Capital Raise
Curative Biotechnology extends executive employment agreements, adjusts compensation, and prepares for a potential capital raise.
Capital raise
Worse than expected